Vectus Biosystems (VBS.AX) Stock Price
Vectus Biosystems Price
Revenue at Vectus Biosystems has contracted by 2.6% per year over the past 12 years to 478,182.00 AUD. Vectus Biosystems's net margin stands at -371.7%, up from -2,145,135.5% several years earlier.
Vectus Biosystems stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Vectus Biosystems business model & stock analysis
Frequently asked questions about Vectus Biosystems
Converted at the current exchange rate, the Vectus Biosystems share trades at 0.05 EUR (0.08 AUD).
The revenue cannot currently be calculated for Vectus Biosystems.
The profit of Vectus Biosystems is 1.56 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Vectus Biosystems is currently 2.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Vectus Biosystems stock.
The P/S cannot be calculated for Vectus Biosystems currently.
The Eulerpool Quality Score for Vectus Biosystems is 3/10.
The ISIN of Vectus Biosystems is AU000000VBS9. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Vectus Biosystems is VBS.AX. The ticker symbol is used to trade Vectus Biosystems shares on the stock exchange.
Vectus Biosystems stock
Vectus Biosystems Peer Group
Vectus Biosystems FIGI
All fundamentals and in-depth analysis of Vectus Biosystems
Our stock analysis for Vectus Biosystems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vectus Biosystems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.